Global Evidence Generation Director Rare Disease 100%

Das ist der Job

We drive it.

Darum lohnt es sich

You will ensure evidence strategies are robust, actionable, and aligned with business priorities — translating plans into impactful studies, scientific communication, and practical insights that support decision-making. /p h3Your new role /h3 pAs Global Evidence Generation Director, you will lead and drive the global evidence generation strategy for Rare Disease in close partnership with therapy area medical teams, regions, key affiliates, clinical development, market access, commercial, safety, regulatory and external scientific stakeholders. /p pYou will be accountable for translating medical and business priorities into an integrated evidence generation approach that supports clinical practice change, scientific communication, and stakeholder engagement.

The role requires strategic judgement, strong cross-functional leadership, and the ability to ensure that evidence activities are prioritised, compliant, scientifically robust and aligned with the Rare Disease ambition. /p h3Your key responsibilities will include: /h3 ul liShape and lead the integrated evidence strategy across the Rare Disease portfolio and brands, ensuring evidence plans are aligned with therapy area strategies and business priorities. /li liDrive design and execution of priority real world evidence (RWE) and Investigator Sponsored Study (ISS) activities, providing expert input on study concepts, coordinating delivery across teams and markets, and ensuring evidence generation supports launch and lifecycle goals. /li liLead and coordinate the evidence team, including Evidence Generation Associate Directors and Project Managers, ensuring clear priorities, strong execution, progress tracking and delivery against timelines, budgets and impact. /li liTranslate evidence into impact, working with Publications, Scientific Communication and cross-functional teams to ensure study outputs are communicated effectively and embedded into key scientific dialogue deliverables. /li liBuild evidence generation capability, acting as a subject matter expert and mentor for the evidence team and wider Medical Affairs organisation. /li liPartner across the enterprise, building strong collaboration with Medical Affairs, Commercial, Market Access, RD, affiliates, RWE/Data Science experts and external stakeholders to address portfolio evidence needs. /li liContribute to Medical Affairs functional leadership team, helping set direction, prioritise resources, develop talent and strengthen a state-of-the-art Medical Affairs organisation focused on advancing patient care. /li /ul h3Your new department /h3 pYou will join Global Medical Affairs Rare Disease, a global organisation dedicated to improving outcomes for people living with rare diseases.

The team works across therapy areas and functional disciplines to generate insights, shape medical strategy, drive scientific dialogue, support clinical care pathways, and build organisational readiness for current and future assets. /p pThe Evidence Generation function plays a central role in ensuring that our strategies are supported by high-quality evidence and that evidence activities are focused on the questions that matter most for patients, healthcare professionals, payers, regulators and healthcare systems.

You will work with highly skilled colleagues across the global Rare Disease organisation and with regional and affiliate teams in key markets. /p h3Your skills and qualifications /h3 pWe are looking for a strategic, collaborative and scientifically strong leader who can operate with confidence in a global, matrixed organisation.

You combine evidence generation expertise with a clear understanding of Medical Affairs impact, external stakeholder needs, cross-functional team needs and the realities of launch and lifecycle management. /p pTo be successful in this role, you will ideally have: /p ul liOver 10 years of evidence generation experience within the pharmaceutical or pharmaceutical service industry, including global, regional, or multi-country exposure, ideally in rare disease or specialty care. /li liProven track record in influential leadership and ability to build and drive high-performing evidence activities and complex strategic projects /li liStrong understanding of pharmaceutical governance, compliance, quality and ethical requirements related to evidence generation and external collaborations. /li liProven ability to build teams and lead cross-functional teams without direct authority, influence senior stakeholders and translate complex evidence topics into clear strategic recommendations. /li liExcellent communication skills in English, with the ability to create alignment, present to senior audiences and engage credibly with scientific experts. /li liA structured, impact-oriented approach to prioritisation, resource allocation and execution in a complex global environment. /li /ul h3Working at Novo Nordisk /h3 pAt Novo Nordisk, we do not wait for change. ph3bGlobal Evidence Generation Director Rare Disease 100% /b /h3 pDirector Global Evidence Generation Rare Disease /p pGlobal Medical Affairs /p pGlobal Rare Disease /p pNovo Nordisk /p pAre you motivated to shape how evidence is generated, integrated and translated into impact for people living with rare diseases?

Do you combine strategic evidence leadership with the drive to turn scientific strategy into high-quality execution, launch readiness and stakeholder value? /p pThis senior role in Global Medical Affairs Rare Disease will set the direction for evidence generation across the Rare Disease portfolio while staying close to delivery.

We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace experimentation, strive for excellence without fixating on perfection, and never shy away from opportunities to develop.

From research and development to manufacturing, marketing, medical affairs and sales, we are all working to move the needle on patient care. /p h3Deadline /h3 pPlease apply by Aug 31st.

Applications will be reviewed on an ongoing basis, and you are encouraged to apply as soon as possible. /p h3Equality of opportunity /h3 pWe commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognise that it is no longer good enough to aspire to be the best company in the world.

We need to aspire to be the best company for the world, and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures.

We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and the communities we operate in. /p pTogether, we are changing life /p pJoin us in shaping evidence that can help transform the future of care for people living with rare diseases. /p ul libWork location /b 8058 Zürich (ZH) /li libWorkload /b 100% /li libEmployment start /b Immediately /li libEmployment duration /b Permanent /li /ul ul libQualification /b skilled /li libWork experience /b More than 3 years /li libEducation /b Master’s degree from a university of applied sciences or equivalent /li /ul ul libEnglish /b Orally : Very good knowledge Written : Very good knowledge /li /ul ul libBy email /b /li /ul /p